Insider · CIK 0001967163

Patel Anish

CIK 0001967163 Name as filed on the most recent filing

Filed as Patel Anish (26)

45 transaction lines · from 26 filings · filed 2023-12-27 to 2026-01-13 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

45 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2026-01-09 S, Open-market sale Enliven Therapeutics, Inc.ELVN 2 lines 1,351,762, disposed Open Form 4 filing 0001967163-26-000001
2025-12-08 S, Open-market sale Enliven Therapeutics, Inc.ELVN 2 lines 140,073, disposed Open Form 4 filing 0001967163-25-000005
2025-11-07 S, Open-market sale Enliven Therapeutics, Inc.ELVN 2 lines 116,034, disposed Open Form 4 filing 0001967163-25-000004
2025-10-07 S, Open-market sale Enliven Therapeutics, Inc.ELVN 133,993, disposed Open Form 4 filing 0001967163-25-000003
2025-09-08 S, Open-market sale Enliven Therapeutics, Inc.ELVN 134,957, disposed Open Form 4 filing 0001415889-25-024196
2025-08-07 S, Open-market sale Enliven Therapeutics, Inc.ELVN 2 lines 121,616, disposed Open Form 4 filing 0001415889-25-021456
2025-07-07 S, Open-market sale Enliven Therapeutics, Inc.ELVN 2 lines 131,951, disposed Open Form 4 filing 0001415889-25-019609
2025-06-09 S, Open-market sale Enliven Therapeutics, Inc.ELVN 2 lines 135,574, disposed Open Form 4 filing 0001415889-25-016734
2025-05-07 S, Open-market sale Enliven Therapeutics, Inc.ELVN 3 lines 122,579, disposed Open Form 4 filing 0001415889-25-012591
2025-04-07 S, Open-market sale Enliven Therapeutics, Inc.ELVN 3 lines 120,269, disposed Open Form 4 filing 0001415889-25-010474
2025-03-07 S, Open-market sale Enliven Therapeutics, Inc.ELVN 142,936, disposed Open Form 4 filing 0001415889-25-007683
2025-02-07 S, Open-market sale Enliven Therapeutics, Inc.ELVN 146,206, disposed Open Form 4 filing 0001415889-25-003515
2025-01-07 S, Open-market sale Enliven Therapeutics, Inc.ELVN 4 lines 685,868, disposed Open Form 4 filing 0001415889-25-001301
2024-10-18 S, Open-market sale Enliven Therapeutics, Inc.ELVN 21,483, disposed Open Form 4 filing 0001415889-24-025505
2024-07-16 S, Open-market sale Enliven Therapeutics, Inc.ELVN 38,692, disposed Open Form 4 filing 0001415889-24-019600
2024-07-15 S, Open-market sale Enliven Therapeutics, Inc.ELVN 776,039, disposed Open Form 4 filing 0001415889-24-019600
2024-07-12 S, Open-market sale Enliven Therapeutics, Inc.ELVN 438,095, disposed Open Form 4 filing 0001415889-24-019600
2024-06-06 S, Open-market sale Enliven Therapeutics, Inc.ELVN 22,722, disposed Open Form 4 filing 0001415889-24-016279
2024-05-14 S, Open-market sale Enliven Therapeutics, Inc.ELVN 27,675, disposed Open Form 4 filing 0001415889-24-013383
2024-05-09 S, Open-market sale Enliven Therapeutics, Inc.ELVN 6,515, disposed Open Form 4 filing 0001415889-24-013071
2024-05-06 S, Open-market sale Enliven Therapeutics, Inc.ELVN 110,769, disposed Open Form 4 filing 0001415889-24-012652
2024-04-11 S, Open-market sale Enliven Therapeutics, Inc.ELVN 438,099, disposed Open Form 4 filing 0001415889-24-010831
2024-04-08 S, Open-market sale Enliven Therapeutics, Inc.ELVN 2 lines 90,687, disposed Open Form 4 filing 0001415889-24-010676
2024-03-06 S, Open-market sale Enliven Therapeutics, Inc.ELVN 76,239, disposed Open Form 4 filing 0001415889-24-007457
2024-02-06 S, Open-market sale Enliven Therapeutics, Inc.ELVN 73,658, disposed Open Form 4 filing 0001415889-24-003122
2024-01-22 S, Open-market sale Enliven Therapeutics, Inc.ELVN 73,783, disposed Open Form 4 filing 0001209191-24-002190
2024-01-02 S, Open-market sale Enliven Therapeutics, Inc.ELVN 165,053, disposed Open Form 4 filing 0001209191-24-000256
2023-12-29 S, Open-market sale Enliven Therapeutics, Inc.ELVN 300, disposed Open Form 4 filing 0001209191-24-000256
2023-12-28 S, Open-market sale Enliven Therapeutics, Inc.ELVN 37,996, disposed Open Form 4 filing 0001209191-24-000256
2023-12-26 S, Open-market sale Enliven Therapeutics, Inc.ELVN 1,531, disposed Open Form 4 filing 0001209191-23-059816
2023-12-22 S, Open-market sale Enliven Therapeutics, Inc.ELVN 14,776, disposed Open Form 4 filing 0001209191-23-059816

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
Relationships on this page
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 0
  • Open-market sale 45
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Patel Anish, insider transactions. Retrieved 2026-08-24 from https://ebomi.com/insider/0001967163

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.